The CD4+ lymphopenic sarcoidosis phenotype is highly responsive to anti-tumor necrosis factor-α therapy

Chest

Volumn 137, Issue 6, 2010, Pages 1432-1435

  Crouser, Elliott D ^a,b   Lozanski, Gerard ^b   Fox, Charity C ^a,b   Hauswirth, David W ^a,b   Raveendran, Rekha ^b   Julian, Mark W ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID;

ADULT; AGED; ARTICLE; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; FEMALE; HUMAN; LYMPHOCYTOPENIA; MALE; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SARCOIDOSIS; T LYMPHOCYTE SUBPOPULATION; TREATMENT RESPONSE;

EID: 77953315221     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-2576     Document Type: Article

References (23)

1. Morell F, Levy G, Orriols R, Ferrer J, De Gracia J, Sampol G. Delayed cutaneous hypersensitivity tests and lymphopenia as activity markers in sarcoidosis. Chest. 2002;121(4): 1239-1244.
2. + T lymphopenia. Thorax. 1996;51(4):446-449.
3. Ross JJ, Katz JD. Cryptococcal meningitis and sarcoidosis. Scand J Infect Dis. 2002;34(12):937-939.
4. Yanardaǧ H, Pamuk GE, Karayel T, Demirci S. Bone marrow involvement in sarcoidosis: an analysis of 50 bone marrow samples. Haematologia (Budap). 2002;32(4):419-425. (Pubitemid 36675315)
5. Desrues B, Delaval P, Genetet N, et al. Does peripheral blood T-lymphocyte population distribution in sarcoidosis provide a prognostic clue? Sarcoidosis. 1991;8(2):129-133.
6. Miyara M, Amoura Z, Parizot C, et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med. 2006;203(2): 359-370.
7. Nadkarni S, Mauri C, Ehrenstein MR. Anti-TNF-α therapy induces a distinct regulatory T cell population in patients with rheu matoid arthritis via TGF-β. J Exp Med. 2007;204(1):33-39.
8. Planck A, Katchar K, Eklund A, Gripenbäck S, Grunewald J. T-lymphocyte activity in HLA-DR17 positive patients with active and clinically recovered sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2003;20(2):110-117. (Pubitemid 36841691)
9. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160(2): 736-755.
10. Sandborn WJ, Hanauer SB. Infliximab in the treatment of Crohn's disease: a user's guide for clinicians. Am J Gastroenterol. 2002;97(12):2962-2972.
11. Blum KA, Hamadani M, Phillips GS, et al. Prolonged myelo-suppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma. Leuk Lymphoma. 2009;50(3):349-356.
12. Baughman RP, Drent M, Kavuru M, et al;Sarcoidosis Investigators . Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med. 2006;174(7):795-802.
13. Judson MA, Baughman RP, Costabel U, et al; Centocor T48 Sarcoidosis Investigators. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J. 2008;31(6):1189-1196.
14. Agostini C, Basso U, Semenzato G. Cells and molecules involved in the development of sarcoid granuloma. J Clin Immunol. 1998;18(3):184-192.
15. Sharma OP, Vucinic V, James DG. Splenectomy in sarcoidosis: indications, complications, and long-term follow-up. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19(1):66-70. (Pubitemid 34298497)
16. Kalajian AH, Van Meter JR, Callen JP. Sarcoidal anemia and leukopenia treated with methotrexate and mycophenolate mofetil. Arch Dermatol. 2009;145(8):905-909.
17. Kataria YP, Whitcomb ME. Splenomegaly in sarcoidosis. Arch Intern Med. 1980;140(1):35-37.
18. + cells. Am J Pathol. 1988;131(2):191-198.
19. + T reg cells. J Exp Med. 2006;203(7):1701-1711.
20. Idali F, Wahlström J, Müller-Suur C, Eklund A, Grunewald J. Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis. Clin Exp Immunol. 2008;152(1):127-137.
21. + CD25hi T-regulatory cells. Blood. 2006;108(1): 253-261.
22. + regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions. Am J Pathol. 2009;174(2): 497-508.
23. Zaba LC, Smith GP, Sanchez M, Prytowsky SD. Dendritic cells in the pathogenesis of sarcoidosis. Am J Respir Cell Mol Biol. 2010;42(1):32-39.